Literature DB >> 33295420

A clinical approach to hypertrophic pachymeningitis.

Fabiano Ferreira Abrantes1, Marianna Pinheiro Moraes de Moraes1, Flávio Moura Rezende Filho1, José Luiz Pedroso1, Orlando Graziani Povoas Barsottini1.   

Abstract

IMPORTANCE: Hypertrophic pachymeningitis (HP) is a non-usual manifestation of rheumatologic, infectious, and neoplastic diseases. Etiological diagnosis is a challenge, but when made promptly it creates a window of opportunity for treatment, with the possibility of a total reversal of symptoms. OBSERVATIONS: HP is an inflammatory process of the dura mater that can occur as a manifestation of sarcoidosis, granulomatosis with polyangiitis, and IgG4-related disease. The HP case evaluation is extensive and includes central nervous system imaging, cerebrospinal fluid analysis, serology, rheumatologic tests, and systemic survey for other manifestations sites. After systemic investigation, meningeal biopsy might be necessary. Etiology guides HP treatment, and autoimmune disorders are treated with corticosteroids alone or associated with an immunosuppressor.
CONCLUSION: HP is a manifestation of several diseases, and a precise etiological diagnosis is crucial because of the difference among treatments. An extensive investigation of patients with HP helps early diagnosis and correct treatment.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 33295420     DOI: 10.1590/0004-282X20200073

Source DB:  PubMed          Journal:  Arq Neuropsiquiatr        ISSN: 0004-282X            Impact factor:   1.420


  2 in total

Review 1.  Immunoglobulin G4-related Disease: A New Systemic Disease Emerging in Japan.

Authors:  Terumi Kamisawa
Journal:  JMA J       Date:  2021-12-15

2.  A Rare Ocular Manifestation of Idiopathic Hypertrophic Cranial Pachymeningitis.

Authors:  Josephine En Hui Lee; Suresh Subramaniam; Chun Fai Cheah; Kok Hoe Chan; Hussein Adil
Journal:  Cureus       Date:  2021-12-23
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.